$BMY has held up remarkably well during the market sell off. That said, I don't think that it's going to escape the downside for that much longer. We've tested the $77-78 region multiple times and just rejected again. Seeing the price action today makes me think that it's finally time for BMY to fall lower. Once $BMY breaks $75, there's not much holding it up. I...
The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 33.33%.
COULD be starting its breakout of the cup & handle that has been in the making for 20+ years that I first mentioned almost a year ago. Would like to see a little more push with good volume in the last hour of today, otherwise could chop around a little more. Target remains $130 if it goes.
BMY looking like a short here. Playing the triple top with the bottom of the channel as the target. Can always scale out with the drop. Options play. Cheap puts $$$$
Possible set up on a triple top. History says its dropped on previous tests
My BMY position with stop loss and target. BMY is flagging after a long uptrend. The flag is a little extended and longer than i'd like, but regardless I opened a small position on the 5 min time frame.
Bought 100 BMY May 6th $75 puts. Will add for each $1.00 increase.
Desicion to Buy. Entry Price = $70.95. Target Price=$71.65. Stop Price=$70.25
This might be forming a long-term base here. I'm long with a stop-loss at $62 (has to be a weekly close below $62). Part of my longest-term trading system.
Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Investments continue to flow into the...
Desicion to Buy. Entry Price = $69.35. Target Price=$70.75. Stop Price=$67.95
Textbook pattern. Pharma products going through the roof due to covid and other reasons why this would be in high demand, also not too mention big investors adding to their portfolio. Plenty of info online, please research before investing obv. trade safe all.
The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 20%.
Looks like a possible Cup and Handle with massive upside is forming in Bristol Myers Squibb. $340 Target
Immediate targets 61, 59, 56, 53. Invalidation at 79. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically...
Healthy pipeline. Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms. Estimates are for about 4-6% the next 2 years. A+ Credit Rating 48LT Debt to Cap PT $96 by 2023 using a 7% earnings growth rate and 12 P/E HUGE saucer...
Immediate targets 61,59, 56, 53. Invalidation at 79. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely...
BMY is presently in a wedge. Though a breakdown is certainly possible over the next decade, what are reasonable breakout levels to watch? This chart with Fib levels induced by the move from all-time lows to all-time highs gives some clues. Approximately $75 is first up, then approximately $120.